AVEO PHARMACEUTICALS INC (AVEOXXXX)
Institutional ownership reported to the SEC as of Q2 2021, across 11 quarters.
1
Reporting holders
$30.0K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Gemmer Asset Management LLC | $30.0K | 1,939 | 0.00% | 11q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2021 | 1 | $30.0K | 1,939 | 0 | 0 | 0 | 0.0% |
| Q1 2021 | 1 | $28.0K | 1,939 | 0 | 0 | 0 | 0.0% |
| Q4 2020 | 1 | $25.0K | 1,939 | 0 | 0 | 0 | 0.0% |
| Q3 2020 | 2 | $462.0K | 76,491 | 0 | 1 | 0 | 0.0% |
| Q2 2020 | 2 | $358.0K | 67,847 | 0 | 1 | 0 | 0.0% |
| Q1 2020 | 2 | $254.0K | 67,197 | 0 | 0 | 2 | 0.0% |
| Q4 2019 | 62 | $28.6M | 43,437,756 | 13 | 11 | 13 | 5.2% |
| Q3 2019 | 62 | $38.8M | 42,796,816 | 8 | 13 | 17 | 6.8% |
| Q2 2019 | 71 | $37.9M | 50,089,982 | 16 | 16 | 22 | 11.3% |
| Q1 2019 | 82 | $40.3M | 45,498,417 | 9 | 19 | 26 | 7.5% |
| Q4 2018 | 98 | $91.8M | 51,047,285 | 3 | 1 | 3 | 10.9% |